BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
Client Focus
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
ECM
Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on ONWARD Medical's EUR 20 million Follow-On Offering
Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on GeNeuro's EUR 5m Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner on Nikola Corporation's USD 275m Combined Offering
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Otovo's NOK 450 million Follow-on Offering
Bryan, Garnier & Co acts as European Lead Manager on Abivax’s USD 236 million Nasdaq IPO
Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners
Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Egetis Therapeutics on a Combined Offering of SEK 462m
Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Median Technologies' EUR 21.6 million Follow-On Offering & Convertible Bonds Issuance
Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Carbios' EUR 141m Rights Issue
Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on HydrogenPro's NOK 126 million Follow-on Offering
1
2
3
4
…
15
Privacy Preference Center
Privacy Preferences